BCIQ Profiles

Company Profile Report

Novavax announces high neutralizing antibody titers in COVID-19 vaccine

A COVID-19 candidate vaccine from Novavax has produced the highest reported levels of neutralizing titers in non-human primate studies.

“We are seeing neutralizing titers in the 10,000 range in non-human primates,” Gregory Glenn, president of R&D at Novavax Inc. (NASDAQ:NVAX), said Tuesday in a presentation to the BIO annual meeting.

Glenn was discussing Novavax’s NVX CoV2373, a

Read the full 572 word article

How to gain access

Continue reading with a
two-week free trial.